Efficacy of levodopa/carbidopa/entacapone vs. levodopa/carbidopa on activities of daily living in patients experiencing early wearing-off

被引：0

作者：

Tolosa, E. ^{[1
]}

Hernandez, B. ^{[2
]}

Linazasoro, G. ^{[3
]}

Lopez-Lozano, J. J. ^{[4
]}

Mir, P. ^{[5
]}

Marey, J. ^{[6
]}

机构：

[1] Hosp Clin Barcelona, Barcelona, Spain

[2] Novartis Farmaceut, Barcelona, Spain

[3] Policlin Gipuzkoa, San Sebastian, Spain

[4] Hosp Puerta Hierro, Madrid, Spain

[5] Hosp Virgen Rocio, Seville, Spain

[6] Hosp Juan Canalejo, La Coruna, Spain

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2009年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：542 / 542

页数：1

共 50 条

[1] Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: a randomised, double-blind trial
Tolosa, Eduardo
Hernandez, Basilio
Linazasoro, Gurutz
Jose Lopez-Lozano, Juan
Mir, Pablo
Marey, Jose
Kulisevsky, Jaime
[J]. JOURNAL OF NEURAL TRANSMISSION, 2014, 121 (04) : 357 - 366
[2] Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial
Eduardo Tolosa
Basilio Hernández
Gurutz Linazasoro
Juan José López-Lozano
Pablo Mir
José Marey
Jaime Kulisevsky
[J]. Journal of Neural Transmission, 2014, 121 : 357 - 366
[3] Significant benefits of the direct switch from conventional levodopa/henserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with early wearing-off
Eggert, K.
Oertel, W. H.
Skogar, Oe.
Amar, K.
Luotonen, L.
Nissinen, H.
[J]. MOVEMENT DISORDERS, 2008, 23 (01) : S215 - S215
[4] Significant benefits of the direct switch from conventional levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with early wearing-off
Eggert, K.
Oertel, W.
Skogar, O.
Amar, K.
Luotonen, L.
Nissinen, H.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 125 - 125
[5] Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off
Mikko Kuoppamäki
Mika Leinonen
Werner Poewe
[J]. Journal of Neural Transmission, 2015, 122 : 1709 - 1714
[6] Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off
Kuoppamaki, Mikko
Leinonen, Mika
Poewe, Werner
[J]. JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (12) : 1709 - 1714
[7] Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations
Reichmann, H
Boas, J
MacMahon, D
Myllyla, V
Hakala, A
Reinikainen, K
[J]. ACTA NEUROLOGICA SCANDINAVICA, 2005, 111 (01): : 21 - 28
[8] Benefits of a direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone on non-motor symptoms of early wearing-off in Parkinson's disease patients
Nissinen, H.
Eggert, K.
Kuoppamaeki, M.
Leinonen, M.
[J]. MOVEMENT DISORDERS, 2008, 23 (01) : S213 - S213
[9] Benefits of a direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone on non-motor symptoms of early wearing-off in Parkinson's disease patients
Nissinen, H.
Eggert, K.
Kuoppamaki, M.
Leinonen, M.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 125 - 125
[10] Efficacy of combining levodopa with entacapone on activities of daily living and quality of life in parkinsonian patients experiencing 'wearing-off' type complications
Reichmann, H
[J]. MOVEMENT DISORDERS, 2004, 19 : S255 - S256

← 1 2 3 4 5 →